Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The bill reauthorizes funding to improve bioterrorism and other public health emergency preparedness and response activities such as the Hospital Preparedness Program, the Public Health Emergency Preparedness Cooperative Agreement, Project BioShield, and BARDA for the advanced research and development of medical countermeasures (MCMs). [18]
Medical countermeasures (MCMs) are products such as biologics and pharmaceutical drugs that can protect from or treat the effects of a chemical, biological, radiological, or nuclear (CBRN) attack, or in the case of public health emergencies. MCMs can also be used for prevention and diagnosis of symptoms associated with CBRN attacks or threats.
BARDA, a division of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR), works to support the development of medical countermeasures such as vaccines, drugs, and diagnostic tools to counteract health security threats.
WASHINGTON (Reuters) -President Joe Biden on Monday invoked a Cold War-era measure to boost investment in U.S. manufacturing of medicines and medical supplies that he has deemed important for ...
Stassi Schroeder's daughter Hartford is dangerously obsessed with Wicked.. On Thursday, Dec. 27, the Vanderpump Rules alum's husband, Beau Clark, shared a hilarious video on Instagram of Schroeder ...
A 40-year-old man has pled guilty to charges of stalking and harassing UConn women's basketball star Paige Bueckers, ESPN reports.. Robert Cole Parmalee, of Grants Pass, Oregon, entered a guilty ...
The government should prioritize innovation and funding for medical countermeasures at agencies with biodefense responsibilities, identify at least five promising novel technologies that could ultimately be applied to MCM development for material threats, revolutionize development of medical countermeasures for emerging infectious diseases with ...